期刊文献+

造血干细胞移植治疗非恶性疾病概述

在线阅读 下载PDF
导出
作者 吴宝玮
出处 《大连医科大学学报》 CAS 2006年第3期249-250,259,共3页 Journal of Dalian Medical University
  • 相关文献

参考文献20

  • 1邹萍.造血干细胞移植在非血液系统疾病中的应用[J].中华内科杂志,2005,44(10):721-723. 被引量:3
  • 2Tyndall A, Gratwohl A . Blood and marrow stem cell transplants in auto - immune disease: a consensus report written on behalf of the European League against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT) [J]. Bone Marrow Transplant, 1997, 19(7): 643-645.
  • 3Burt RK. BMT for severe autoimmune diseases: an idea whose time has come [J]. Oncology (Williston Park),1997,11(7): 1001-1017.
  • 4Hahn BH. The potential role of autologous stem cell transplantation in patients with systemic lupus erythemaatosus[J], J Rheumatol Suppl, 1997, 48: 89-93.
  • 5Van Laar JM, Tyndall A. Intense immunosuppression and stem- cell transplantation for patients with severe rheumatic autoimmune disease a review [J]. Cancer Control,2003; 10:57-65.
  • 6赵晓武,侯天德,符粤文,吴书一,董秀娟,马红霞,吴艳.自体造血干细胞移植治疗重型系统性红斑狼疮[J].中华内科杂志,2003,42(3):200-202. 被引量:18
  • 7Mysler E, Bini P, Drappa J, et al. The apoptosis- 1/Fas protein in human systemic lupus erythematosus [J]. J Clin Invest, 1994;93(3): 1029 - 1034.
  • 8Ohsako S, Hara M, Harigai M, et al. Expression and function of Fas antigen and bcl - 2 in human systemic lupus erythematosus lymphocytes [J]. Clin Immunol Immunopath, 1994;73(1): 109 - 114.
  • 9Gatenby PA, Irvine M. The bcl- 2 proto - oncogene is overexpressed in systemic lupus erythematosus [J]. J Autoimmune, 1994; 7(5): 623-631.
  • 10Yurovsky VV, Sutton PA, Schulze DH, et al. Expansion of selected Vδ1+rδ T cells in systemic sclerosis patients[J]. J Immunol, 1994; 153(2): 881-891.

二级参考文献43

  • 1朱为国,邢献志,吴霭,武大林.人脐血造血干细胞深低温保存效果观察[J].中华血液学杂志,1994,15(4):201-202. 被引量:16
  • 2张乃峥.系统性红斑狼疮[A].张乃峥 主编.临床风湿病学:第1版[C].上海: 科学技术出版社,1999.183-212.
  • 3Tyndall A, Gratwohl A. Blood and marrow stem cell transplants in auto-immune disease: a consensus report written on behalf of the European League against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT).Bone Marrow Transplant, 1997,19: 643-645.
  • 4Tyndall A, Gratwohl A. Hemopoietic blood and marrow transplants in the treatment of severe autoimmune disease. Curr Opin Hematol,1997,4:390-394.
  • 5Burt RK. BMT for severe autoimmune diseases: an idea whose time has come. Oncology (Huntingt),1997,11:1001-1017.
  • 6Hahn BH. The potential role of autologous stem cell transplantation in patients with systemic lupus erythematosus. J Rheumatol Suppl,1997,48:89-93.
  • 7Van Laar JM,Tyndall A. Intense immunosuppression and stem-cell transplantation for patients with severe rheumatic autoimmune disease: a review. Cancer Control,2003,10:57-65.
  • 8Burt RK, Traynor AE, Craig R, et al. The promise of hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant,2003,31:521-524.
  • 9Oksenberg JR, Hauser SL. Emerging concepts of pathogenesis:relationship to multiple sclerosis therapies. In: Rudick RA,Goodkin DE (eds). Multiple sclerosis therapeutics. MartinDunitz: London, 1999.215-242.
  • 10Burt RK, Traynor AE, Cohen B,et al. T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: report on the first three patients. Bone Marrow Transplant,1998,21: 537-541.

共引文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部